Your Path to Starts Here

The outpatient treatment program at NeuDefense is grounded in a personalized, science-based approach that integrates genetics, neuro-nutrient therapy, and structured behavioral support. Drawing from decades of published research on Reward Deficiency Syndrome (RDS), dopamine imbalance, and integrative recovery models, this program is designed to help clients achieve lasting behavioral change without the need for inpatient care.

At the core of the program is the Predict IQ genetic test, which identifies individual predispositions to addiction, impulsivity, and related behavioral health challenges. These insights guide the use of Synapta+, our patented neuro-nutrient formula, to optimize dopamine function and restore neurochemical balance. This biochemical support enhances the brain’s ability to respond to therapy, reduce cravings, and improve emotional regulation.

Clients participate in a structured outpatient protocol that includes:

• Weekly or biweekly clinical check-ins

• Cognitive-behavioral therapy (CBT) or similar evidence-based counseling

• Personalized supplementation based on genetic findings

• Compliance monitoring and progress reporting for legal or court-related documentation